Golden Valley, MN The FDA Circulatory Systems Device Panel has recommended approval of the Amplatzer ® Septal Occluder along with the Amplatzer ® Delivery System for patients with secundum atrial ...

Abbott is recalling the steerable sheath used to deliver its Amplatzer Amulet Left Atrial Appendage Occluder, saying there is an increased risk of air emboli being introduced to patients undergoing ...

The FDA has issued its most serious label to an Abbott recall of delivery catheters used for a specific minimally invasive heart surgery, due to a risk of introducing dangerous air bubbles into the ...

Sahajanand Medical Technologies (SMT) is using its Cocoon Occluder devices to treat congenital heart defects like atrial septal defect and patent foramen ovale. These minimally invasive devices ...

First and only steerable delivery system designed to help seal the left atrial appendage (LAA) in people with atrial fibrillation who are at an increased risk of stroke Now available in the U.S., ...

May 26, 2012 (Silver Spring, Maryland) — More studies of atrial septal defect (ASD) occluders are needed to better understand the incidence and causes of rare life-threatening adverse events related ...

Abbott’s Amplatzer Amulet Left Atrial Appendage Occluder was approved nearly two years ago. Here are five things to know about the minimally invasive device: 1. The product closes the left atrial ...

Abbott’s range of entries to Fast Company’s 2o20 World Changing Ideas Awards made it our selection for World Changing Company of the Year. While the company is currently a major player in helping ramp ...

Photo Credit: Hermiller J. AMULET: device characteristics, procedural technique, clinical outcomes, and ongoing studies. Presented at: TCT 2019. The US Food and Drug Administration has approved the ...

Abbott Laboratories ABT recently received FDA approval for its Amplatzer Talisman PFO Occlusion System to treat patent foramen ovale (PFO) patients at risk of recurrent ischemic stroke. The ...

Abbott Laboratories ABT recently launched its Amplatzer Talisman PFO Occlusion System in Europe. The Talisman device aims to treat patent foramen ovale (PFO) patients who have had a stroke and are at ...

Abbott Laboratories received FDA approval for its Amplatzer Amulet left atrial appendage occluder to treat people with atrial fibrillation who are at risk of ischemic stroke about a month earlier than ...